Khetsuriani Nino, Quiroz Eva S, Holman Robert C, Anderson Larry J
Respiratory and Enteric Viruses Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
Neuroepidemiology. 2003 Nov-Dec;22(6):345-52. doi: 10.1159/000072924.
We used the National Hospital Discharge Survey and the Nationwide Inpatient Sample of the Health Care Cost and Utilization Project to estimate disease burden associated with viral meningitis hospitalizations in the United States. During 1988-1999, viral meningitis accounted for an estimated 434,000 hospitalizations (annual average, 36,000; average annual hospitalization rate, 14/100,000), and 2.1 million hospital days (annual average, 175,000). The estimated mean charge for viral meningitis-associated hospitalization during 1993-1997 varied between USD 6,562 and 8,313, resulting in annual estimated hospitalization costs between USD 234 and 310 million and a total estimated cost of nearly USD 1.3 billion for the 5-year period. In summary, viral meningitis remains an important cause of morbidity and financial burden and merits efforts to improve diagnostic, treatment, and prevention options.
我们利用国家医院出院调查以及医疗成本和利用项目的全国住院患者样本,来估算美国与病毒性脑膜炎住院相关的疾病负担。在1988 - 1999年期间,病毒性脑膜炎估计导致了43.4万例住院(年均3.6万例;年均住院率为14/10万),以及210万住院日(年均17.5万)。1993 - 1997年期间,与病毒性脑膜炎相关住院的估计平均费用在6562美元至8313美元之间,导致年均估计住院费用在2.34亿美元至3.10亿美元之间,5年期间的总估计费用近13亿美元。总之,病毒性脑膜炎仍是发病和经济负担的一个重要原因,值得努力改善诊断、治疗和预防方法。